Bluejay Diagnostics Ownership | Who Owns Bluejay Diagnostics?
Bluejay Diagnostics Ownership Summary
Bluejay Diagnostics is owned by 10.39% institutional investors, 2.03% insiders, and 87.57% retail investors. Geode capital management is the largest institutional shareholder, holding 0% of BJDX shares. Fidelity Extended Market Index is the top mutual fund, with 0.55% of its assets in Bluejay Diagnostics shares.
BJDX Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Bluejay Diagnostics | 10.39% | 2.03% | 87.57% |
| Sector | Healthcare Stocks | 244.59% | 12.11% | -156.70% |
| Industry | Medical Device Stocks | 52.73% | 12.62% | 34.65% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Geode capital management | - | - | - |
| Ubs group | - | - | - |
| Sabby management | - | - | - |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Geode capital management | - | - | - |
| Ubs group | - | - | - |
| Sabby management | - | - | - |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Ubs group | - | - | -124.00 |
| Geode capital management | - | - | -28.13K |
| Sabby management | - | - | -28.73K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Sabby management | - | - | -28.73K |
| Geode capital management | - | - | -28.13K |
| Ubs group | - | - | -124.00 |
Sold Out
| Holder | Change |
|---|---|
| Ubs group | -124.00 |
| Geode capital management | -28.13K |
| Sabby management | -28.73K |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2026 | 8 | 33.33% | 216,120 | 267.37% | 10 | 129.84% | 6 | 50.00% | 1 | -50.00% |
| Mar 31, 2026 | 6 | - | 58,829 | - | 13 | - | 6 | - | - | - |
| Sep 30, 2023 | 1 | -90.91% | 12 | -99.99% | - | 3.04% | - | -100.00% | - | -100.00% |
| Jun 30, 2023 | 11 | 10.00% | 178,714 | 30.68% | - | 194.70% | 6 | 50.00% | 1 | -75.00% |
| Mar 31, 2023 | 10 | -16.67% | 136,756 | -52.34% | - | 33.14% | 4 | -33.33% | 4 | 100.00% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Fidelity Extended Market Index | 5.67K | 0.55% | -19.48K |
| NT Ext Equity Mkt Index Fund - NL | 891.00 | 0.09% | 891.00 |
| NT Ext Equity Mkt Idx Fd - DC - NL - T2 | 646.00 | 0.06% | 646.00 |
| Fidelity Series Total Market Index | 183.00 | 0.02% | - |
| Spartan Extended Market Index Pool F | 102.00 | 0.01% | - |
| Vanguard Institutional Extnd Mkt Idx Tr | 98.00 | 0.00% | - |
| NT Ext Eq Mkt Indx Fd DC Lending Tier 5 | 11.00 | 0.00% | - |
| SSgA U.S. Total Market Index Strategy | 2.00 | - | - |
| NT Ext Equity Mkt Idx Fd - L | 1.00 | - | - |
| SSgA U.S. Extended Market Index Class I | 45.00 | - | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Jul 09, 2026 | HRT FINANCIAL LP | - | Buy | $96.71K |
| Jul 10, 2026 | HRT FINANCIAL LP | - | Sell | $48.91K |
| Mar 14, 2026 | Wurth Douglas Clark | - | Buy | $25.00K |
| Mar 14, 2026 | Dey Indranil | President and CEO | Buy | $25.00K |
| Mar 14, 2026 | CHASE DONALD R | - | Buy | $25.00K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q3 | 1 | 1 |
| 2026 Q1 | 5 | - |
| 2023 Q4 | 2 | - |
| 2023 Q3 | - | - |
| 2023 Q1 | 3 | - |
BJDX Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools